Antithrombin-mediated Inhibition of Factor Vlla-Tissue Factor Complex by the Synthetic Pentasaccharide Representing the Heparin Binding Site to Antithrombin

Summary

We examined the effect of the synthetic pentasaccharide representing the minimal binding site of heparin to antithrombin on the antithrombin-mediated inactivation of factor Vila bound to tissue factor. This effect was compared to the effect of unfractionated heparin. Using purified recombinant human coagulation factors and either a clotting or an amidolytic assay for the determination of the residual activity of factor Vila, we showed that the pentasaccharide was an efficient antithrombin-dependent inhibitor of the coagulant activity of tissue factor-factor Vila complex. In our experimental conditions, assuming a mean MW of 14,000 for heparin, the molar pseudo-first order rate constants for ATIII-mediated FVIIa inhibition by ATIII-binding heparin and by the synthetic pentasaccharide were found to be similar with respective values of 104,000 ± 10,500 min-1 and 112,000 ± 12,000 min-1 (mean ± s.e.m., n = 3)

• References

• 1 Rao LVM, Rapaport SI. Activation of factor VII bound to tissue factor: A key early step in the tissue factor pathway of blood coagulation. Proc Natl Acad Sci USA 1988; 85: 6686-6691
• 2 Nemerson Y. Tissue factor and haemostasis. Blood 1988; 71: 1-8
• 3 Rapaport SI, Rao LVM. Initiation and regulation of tissue factor-dependent blood coagulation. Arteriosclerosis and Thrombosis 1992; 12: 1111-1121
• 4 Broze Jr GJ, Girard TJ, Novotny WF. Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochem 1990; 29: 7539-7546
• 5 Rapaport SI. The extrinsic pathway inhibitor: A regulator of tissue factor-dependent blood coagulation. Thromb Haemost 1991; 66: 6-15
• 6 Godal HC, Rygh M, Laake K. Progressive inactivation of purified factor Vila by heparin and antithrombin III. Thromb Res 1974; 5: 773-775
• 7 Kondo S, Kisiel W. Regulation of factor Vila activity in plasma: Evidence that antithrombin III is the sole plasma protease inhibitor of factor Vila. Thromb Res 1987; 46: 325-335
• 8 Jesty J. The inhibition of activated bovine coagulation factors X and VII by antithrombin III. Arch Biochem Biophys 1978; 185: 165-173
• 9 Osterud B, Miller-Andersson M, Abildgaard U, Prydz H. The effect of antithrombin III on the activity of the coagulation factors VII, IX and X. Thromb Haemost 1976; 35: 295-304
• 10 Rao LMV, Rapaport SI, Hoang AD. Binding of factor Vila to tissue factor permits rapid antithrombin Ill/heparin inhibition of factor Vila. Blood 1993; 81: 2600-2607
• 11 Rao LMV, Nordfang O, Hoang AD, Pendurthi UR. Mechanism of antithrombin III inhibition of factor Vila/tissue factor activity on cell surfaces. Comparison with tissue Factor Pathway Inhibitor/factor Xa-induced inhibition of factor Vila/tissue factor activity. Blood 1995; 85: 121-129
• 12 Lawson JH, Butenas S, Ribarik N, Mann KG. Complex-dependent inhibition of factor Vila by antithrombin III and heparin. J Biol Chem 1993; 268: 767-770
• 13 Broze Jr GJ, Likert K, Higuchi D. Inhibition of factor Vila/tissue factor by antithrombin III and tissue factor pathway inhibitor. Blood 1993; 82: 1679-1690
• 14 Choay J, Petitou M, Lormeau JC, Sinay P, Casu BJ, Gatti G. Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity. Biochem Biophys Res Commun 1993; 116: 492-499
• 15 Lormeau JC, Herault JP. Comparative inhibition of extrinsic and intrinsic thrombin generation by standard heparin, a low-molecular weight heparin and the synthetic ATIII-binding pentasaccharide. Thromb Haemost 1993; 69: 152-156
• 16 Hobbelen PMJ, Van Dinther TG, Vogel GM, Van Boeckel CAA, Moelker HCT, Meuleman DG. Pharmacological profile of the chemically synthe-tized antithrombin III binding fragment of heparin (pentasaccharide) in rats. Thromb Haemost 1990; 63: 265-270
• 17 Amar J, Caranobe C, Sie P, Boneu B. Antithrombotic potencies of heparins in relation to their antifactor Xa and antithrombin activities: an experimental study in two models of thrombosis in the rabbit. Br J Haematol 1990; 76: 94-100
• 18 Scully MF. Kinetic considerations on the physiologic control of thrombin and factor Xa. Sem Thromb Haemost 1992; 18: 218-223
• 19 Lormeau JC, Herault JP. The effect of the synthetic pentasaccharide SR 90107/ORG 31540 on thrombin generation ex vivo is uniquely due to ATIII-mediated neutralization of factor Xa. Thromb Haemost 1995; 74: 1474-1477
• 20 Nordenman B, Danielsson A, Bjork I. The binding of low affinity and high affinity heparin to antithrombin. Fluorescence studies. Eur J Biochem 1978; 90: 1-6
• 21 Crepon B, Donat F, Barzu T, Herault JP. Pharmacokinetic parameters of ATIII-binding pentasaccharides in three animal species: Predictive value for humans. Thromb Haemost 1993; 69: 403
• 22 Boneu B, Necciari J, Magnani H, Kieffer G, Mant T, Morrison P, Singer B, Lamond G, Dickinson J. Pharmacokinetics of the natural pentasaccharide (SR 90107A/ORG 31540) with high affinity for antithrombin III following subcutaneous administration in man. Thromb Haemost 1993; 69: 406 (Abstr)
• 23 Olson TS, Bjork I, Sheffer R, Craig PA, Shore JD, Choay J. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrom-bin-proteinase reactions. J Biol Chem 1992; 267: 12528-12538